Cargando…
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
PURPOSE: To evaluate the effect of immunotherapy on response, survival, and certain immune markers in patients with small cell lung cancer (SCLC) who are receiving chemotherapy. PATIENTS AND METHODS: Patients with SCLC (n = 164) were assigned to receive either chemotherapy alone (group A) or a combi...
Autores principales: | Zarogoulidis, Konstantinos, Ziogas, Eftimios, Boutsikou, Efimia, Zarogoulidis, Paul, Darwiche, Kaid, Kontakiotis, Theodoros, Tsakiridis, Kosmas, Porpodis, Konstantinos, Latsios, Dimitrios, Chatzizisi, Olga, Karapantzos, Ilias, Li, Qiang, Kyriazis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726438/ https://www.ncbi.nlm.nih.gov/pubmed/23901264 http://dx.doi.org/10.2147/DDDT.S43184 |
Ejemplares similares
-
New dilemmas in small-cell lung cancer TNM clinical staging
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013) -
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013) -
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
por: Boutsikou, Eftimia, et al.
Publicado: (2013) -
Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice
por: Boutsikou, Efimia, et al.
Publicado: (2018) -
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
por: Kallianos, Anastasios, et al.
Publicado: (2013)